Pharmacokinetics of budesonide in children and adults with Crohn's disease given budesonide capsules (Entocart© EC)

被引：0
|
作者：
Lundin, P
Lindquist, B
Persson, T
Edsbacker, S
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W1001
引用
收藏
页码：A547 / A547
页数：1
相关论文
共 50 条
  • [21] Oral budesonide in the management of Crohn's disease
    Hofer, KN
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1457 - 1464
  • [22] Budesonide or prednisolone in active Crohn's disease
    Baert, F
    Rutgeerts, P
    ANNALS OF MEDICINE, 1995, 27 (06) : 631 - 631
  • [23] Budesonide for induction of remission in Crohn's disease
    Rezaie, Ali
    Kuenzig, M. Ellen
    Benchimol, Eric I.
    Griffiths, Anne Marie
    Otley, Anthony R.
    Steinhart, A. Hillary
    Kaplan, Gilaad G.
    Seow, Cynthia H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [24] Budesonide for induction of remission in Crohn's disease
    Otley, A.
    Steinhart, A. H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):
  • [25] Budesonide in the management of patients with Crohn's disease
    Thomson, A
    Sadowski, D
    Jenkins, R
    Wild, G
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 11 (03) : 255 - 260
  • [26] Budesonide (Entocort®EC) capsules versus mesalamine (Pentasa®) in active Crohn's disease:: Is there a benefit in continuing treatment beyond 8 weeks?
    Thomsen, OO
    Cortot, A
    Jewell, D
    Wright, JP
    Winter, T
    Veloso, FT
    Vatn, M
    Persson, T
    Pettersson, E
    GASTROENTEROLOGY, 2002, 122 (04) : A501 - A501
  • [27] Targeted delivery of oral budesonide (Entocort® capsules) in healthy volunteers and Crohn's disease patients
    Lundin, P
    Edsbacker, S
    Larsson, P
    Wollmer, P
    GASTROENTEROLOGY, 2001, 120 (05) : A749 - A749
  • [28] Budesonide capsules prolong time to relapse in Crohn's disease patients with medically induced remission
    Sandborn, WJ
    Feagan, BG
    Lofberg, R
    Campieri, M
    Greenberg, GR
    Hanauer, SB
    GASTROENTEROLOGY, 2003, 124 (04) : A381 - A381
  • [29] Safety of budesonide capsules for the treatment of Crohn's disease: Post-marketing surveillance data
    Lichtenstein, GR
    Bengtsson, B
    Danilewitz, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S317 - S318
  • [30] Healthcare cost savings with budesonide controlled ileal release capsules (CIR) in Crohn's disease
    Lofberg, R
    Danielsson, A
    Floren, CH
    Borg, S
    Ericsson, K
    GASTROENTEROLOGY, 2001, 120 (05) : A749 - A749
12345